Sarah A. Teichmann

Director

Sarah A. Teichmann (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in 10x Genomics, Inc. (TXG). The largest single filing was $432K of TXG (7,551 sh across 2 lots, as filed), executed Aug 13.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 2 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$579K

shares × price, as filed

Last traded

Aug 14

Filed Aug 17

Median ADV $190.4M across their filed names

Open performance→

Volume by month

Buys $0 Sells $579K

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 2 filings

Sector per market data · by filing · past 12 months

Most traded names

TXG

10x Genomics, Inc. TXG · 0 buys · 2 sells 2 filings

Recent filings

TXGSALE 10x Genomics, Inc. View filing → $432K
7,551 sh across 2 lots
Exec Aug 13
Filed Aug 17 · 4:08 PM ET TXGSALE 10x Genomics, Inc. View filing → $147K
7,579 sh × $19.41
Exec Feb 25
Filed Feb 27 · 5:30 PM ET